About
Dr. Michael Ghalchi graduated summa cum laude from the University of Pennsylvania before earning his medical degree from the New York University School of Medicine. He completed a fellowship in Cardiovascular Disease and holds advanced certification in Nuclear Cardiology. He is board-certified in cardiology and carries over two decades of clinical experience in internal medicine and cardiovascular disease.
Dr. Ghalchi serves as teaching faculty at NYU School of Medicine and as Honorary Police Surgeon for the NYPD. He founded Manhattan Cardiovascular Associates and Apollo 360 Health, a platform focused on preventive and lifestyle medicine. At Apollo House, he applies precision diagnostics and data-driven protocols to help patients build longer, stronger health trajectories. He also advises several national healthcare organizations. His clinical focus spans longevity medicine, advanced cardiovascular diagnostics, hormone therapy, and metabolic health.
Education & Training
Undergraduate
University of Pennsylvania (summa cum laude)
Medical School
NYU School of Medicine
Fellowship
Fellowship in Cardiovascular Disease
Additional Training
Advanced Certification in Nuclear Cardiology
Certifications
Conditions Treated
Who is Dr. Ghalchi right for?
Dr. Ghalchi is a strong fit for adults who want a physician-led approach to long-term health and performance. Patients with cardiovascular risk factors, metabolic concerns, or hormone imbalances benefit from his precision diagnostics focus. Executives and high-performers seeking comprehensive annual assessments and data-driven health planning work well with his model. His panel stays capped at 150 members, supporting consistent access and thorough evaluations.
Similar Doctors Nearby
Dr. Alan SpiegelMD
arrhythmias, cardiovascular disease, hypertension +1 more
Dr. Dennis EhrichM.D. FACC
cardiovascular disease, hypertension, high cholesterol +2 more
Dr. Aeshita DwivediMD
heart disease, coronary artery disease, cardiovascular risk +3 more
Frequently Asked Questions
Dr. Ghalchi specializes in cardiology, longevity medicine, preventive care, and metabolic health. He applies advanced cardiovascular diagnostics and data-driven protocols to help patients optimize their long-term health. His clinical focus also includes hormone therapy and executive health.
Yes. Dr. Ghalchi holds board certification in cardiology and carries advanced certification in Nuclear Cardiology. He earned his medical degree from NYU School of Medicine and completed a fellowship in Cardiovascular Disease.
Dr. Ghalchi earned his undergraduate degree summa cum laude from the University of Pennsylvania. He then completed his medical degree at NYU School of Medicine and went on to complete a fellowship in Cardiovascular Disease.
Yes. Dr. Ghalchi serves as teaching faculty at NYU School of Medicine. He also holds the role of Honorary Police Surgeon for the NYPD and advises several national healthcare organizations.
Dr. Ghalchi founded Manhattan Cardiovascular Associates and Apollo 360 Health. Apollo 360 Health focuses on preventive and lifestyle medicine. At Apollo House, he brings that same preventive philosophy to a broader longevity and performance model.
Dr. Ghalchi uses precision diagnostics and data-driven protocols to guide each patient's care plan. He focuses on building longer, stronger health trajectories rather than reactive treatment. His evaluations include comprehensive cardiovascular assessments and personalized metabolic and hormone analysis.
Dr. Ghalchi treats cardiovascular disease, hypertension, metabolic disorders, hormone imbalances, and age-related health concerns. He also works with patients on weight management and preventive care strategies. His clinical scope spans both acute cardiovascular concerns and long-term longevity planning.
Dr. Ghalchi caps his panel at 150 founding members. That limit allows him to deliver thorough, personalized care to each patient. Founding availability is limited, and the practice accepts new patients through Zocdoc and its Boulevard booking platform.
Doctor profile last updated March 21, 2026